StecherR.M., HershA.H., SolomanW.M.. The heredity of gout and its relationship to familiar hyperuricemia.Ann Intern Med1949; 31: 595–614
2.
SeegmillerJ.E., RosenbloomF.M., KelleyW.N.. Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis.Science1967; 155: 1682–4
McCartyD.J.. A historical note: Leeuwenhoek's descriptions of crystals from a gouty tophus.Arthritis Rheum1970; 13: 414–8
6.
GarrodA.B.. Nature and Treatment of Gout and Rheumatic Gout.London: Walton and Maberly, 1849
7.
FreudwielerM.. Experimental investigations into the origins of gouty tophi. Translated by Brill JM, McCarty DJ.Arthritis Rheum1965; 8: 267–88
8.
McCartyD.J., HollanderJ.L.. Identification of urate crystals in gouty synovial fluid.Ann Intern Med1961; 54: 452–60
9.
KohnN.N., HughesR.E., McCartyD.J., FairesJ.S.. The significance of calcium phosphate crystals in the synovial fluid of arthritic patients: the ‘pseudogout syndrome’. II Identification of crystals.Ann Intern Med1962; 56: 738–45
10.
FairesJ.S., McCartyD.J.. Acute synovitis in normal joints of man and dog produced by injection of macrocrystalline sodium urate, calcium oxalate and corticosteroid esters.Arthritis Rheum1962; 5: 295–6
11.
SeegmillerJ.E., HowellR.R., MalawistaS.E.. The inflammatory reaction to sodium urate. Its possible relationship to the genesis of acute gouty arthritis.J Am Med Ass1962; 180: 469–75
12.
DieppeP.A., CalvertP.. Crystals and Joint Disease.London: Chapman & Hall, 1983
13.
TurkeltaubR.A.. Gout: questions that still need to be answered.Ann Rheum Dis1995; 54. 79–81
14.
KennedyT.D., HiggensC.S., WoodrowD.F., ScottJ.T.. Crystal deposition in the knee and great toe joints of asymptomatic gout patients.J R Soc Med1984; 77: 747–50
15.
RodnanG.P.. Treatment of the gout and other forms of crystal-induced arthritis.Bull Rheum Dis1967; 32: 43–53
16.
FowlerP.D.. Marrow toxicity of the pyrazoles [Abstract].Ann Rheum Dis1967; 26: 344
17.
MarsonF.G.W.. Studies in gout, with particular reference to the value of sodium salicylate in treatment.QJ Med NS1933; 22: 331
18.
YüT-F, GutmanA.B.. Studies of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanism for excretion of urate in man.J Clin Invest1959; 38: 1298–315
19.
WolfsonW.Q., CohnC., LevineR., HuddlestunB.. Transport and excretion of uric acid in man XXI Physiologic significance of the uricosuric effect of caronamide [Abstract].Am J Med1948; 4: 774
20.
RundlesR.W., WyngaardenJ.B., HitchingsG.H., ElionB.G., SilbermanH.R.. Effects of a xanthine oxidase inhibitor on thiopurine metabolism, hyperuricemia and gout.Trans Assoc Am Phys1963; 76: 126–40
21.
WuX., WakamiyaM., VaishnavS.Hyperuricemia and urate nephropathy in urate oxidase-deficient mice.Proc Nat Acad Sci USA1994; 91: 742–6
22.
RozenbergS., RocheB., DorentR.Urate-oxidase for the treatment of gout in heart transplant recipients. A report of three cases [English edn].Rev Rheum1995; 62(5): 392–4